pocketful logo light
pocketful logo light
Abbott India Ltd logo

Abbott India Ltd

NSE: ABBOTINDIA BSE: 500488

₹27800

(0.89%)

Sun, 09 Aug 2026, 11:02 am

mtf coin illustrationMTF 5x

Abbott India Share Price Live Chart

1 Day

(0.89%)

No Result Found

Summary

  • Market Cap (in Cr)

    57113.63

  • Net Profit (in Cr)

    1414.44

  • P/B

    15.43

  • Sector P/E

    44.89

  • P/E

    46.17

  • EV/EBITDA

    32.42

  • Debt/Equity (Industry)

    0.08

  • Interest Cover (Industry)

    42.77

  • ROCE (Industry)

    23.88

  • RONW (Industry)

    19.04

  • ROE

    37.86

  • ROCE

    54.90

  • Debt/Equity

    0.02

  • EPS (TTM)

    730.36

  • Dividend Yield

    1.77

  • Book Value

    2246.68

  • Interest Cover

    655

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Dividends paid are well covered by earnings (2.6x coverage).
  • Dividends per share have been stable in the past 10 years.
  • Abbott India's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Abbott India is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
thumbs up icon

Cons

  • Abbott India's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • High level of physical assets or inventory.
  • The average tenure for the Abbott India board of directors is less than 3 years, this suggests a new board.
  • Abbott India is not covered by any analysts.
  • Abbott India's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters74.9974.9974.9974.9974.99
FII0.260.180.160.160.16
DII8.939.009.119.198.92
Public15.8115.8315.7515.6615.93
Government00000

Read More

Technical Analysis

RSI

55.60

MACD

258.04

50 DMA

26862.10

200 DMA

27449.12

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic34510309402937027370258002380020230
Fibonacci3094029576.2628733.742737026006.2625163.7423800
Camarilla28781.7528454.5028127.252737027472.7527145.5026818.25

Pivots Level: Classic

R3

+7140

34510

R2

+3570

30940

R1

+2000

29370

27370
27370
Pivot Point
LTP: 27835

S1

-1570

25800

S2

-3570

23800

S3

-7140

20230

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    27843.86

  • 20-EMA

    27693.77

  • 30-EMA

    27496.09

  • 50-EMA

    27224.33

  • 100-EMA

    27106.99

  • 200-EMA

    27602.71

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
11 May 2026agm
11 May 2026board-meetingsAccounts, Quarterly Results, Final Dividend
12 Feb 2026board-meetingsQuarterly Results, Nine Months Results
06 Nov 2025board-meetingsQuarterly Results
25 Jun 2025dividendFinal Dividend - Rs. - 47525 Jul 2025
15 May 2025agm
15 May 2025dividend₹475.00 Dividend /Share25 Jul 2025
19 Jun 2024dividendFinal Dividend - Rs. - 41019 Jul 2024
09 May 2024dividend₹410.00 Dividend /Share19 Jul 2024
09 May 2024agm

Read More

Peer Comparison

Abbott India Ltd logo

Abbott India Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Cipla Ltd logo

Cipla Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Read More

Abbott India Ltd About

Abbott India is leading multinational pharmaceutical companies in India and operates with an owned manufacturing facility in Goa and various independent contract/third party manufacturers based across the country.

Industry

Pharmaceuticals - Multinational

Founded

1944

Headquarters

CEO

Munir Shaikh

Employees

Contact

Website icon

Website

http://www.abbott.co.in

Email icon

Email

investorrelations.india@abbott.com; webmaster@abbo

Phone icon

Phone

91-22-67978888/50461000/2000/1119

Location icon

Location

Unit No 3 Corporate Park, Sion Trombay Road Chembur, Mumbai, Maharashtra, 400071

Read More

Abbott India Ltd Company History

YearHistory
2021
  • Launched Pandemic Defense Coalition.
  • Launched Brufen Power spray.
  • Launched device for treatment of premature babies and newborns with heart openings.
  • Launched new Pediasure for catch-up growth in children.
2022
  • Announced collaborations for holistic diabetes care.
  • Launched Arachitol Gummies for Vitamin D and Calcium.
  • Launched Grow Right 2.0 for child growth.
  • Launched Ensure with HMB for muscle protection and strength.
  • Launched Navitor TAVI system for aortic stenosis.
2023
  • Launched Vertigo Coach app.
  • Launched Pediasure with Nutri-Pull system.
  • Launched vascular imaging platform powered by Ultreon 1.0 Software.
  • Launched XIENCE Sierra Everolimus Eluting Coronary Stent System.
2024
  • Launched next-generation Xience Sierra stent.
  • Launched GLP systems Track automation solutions.
  • Inaugurated innovative outreach centers with Yrgcare.
  • Launched Aveir Vr leadless pacemaker system.
2025
  • Launched new advanced formulation of Ensure Diabetes Care.
  • Launched AVEIR dual chamber leadless pacemaker system.
  • Introduced lab-based blood test to evaluate concussion.
  • Launched next-gen Freestyle Libre 2 Plus with continuous glucose readings and alarms.
  • Introduced Navitor Vision in India for aortic stenosis.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
RELIANCE MUTUAL FUND (SCHEME : RELIANCE CAPITAL TRUSTEE CO.bulkBuy199441143717 May 2011
ABBOTT CAPITAL INDIA LIMITEDbulkSell2240001437.9317 May 2011
ARION COMMERCIAL PVT LTDbulkBuy79203728.3530 Sept 2009
HDFC TRUSTEE CO LTD A C HDFC LONG TERM EQUITY FUNDbulkSell305807510.1329 Jun 2007
RELIANCE CAPITAL TRUSTEE CO LTD A C RELIANCE LONG TERM EQUITbulkBuy29975051029 Jun 2007

Read More

Abbott India Ltd News

Abbott India shares FY26 annual report link

Abbott India Limited has provided the web-link for its Annual Report for FY26. The report is available on the company website and BSE.

20 Jul 2026

companies

Abbott India files BRSR for FY 2025-26

Abbott India filed its Business Responsibility and Sustainability Report for FY 2025-26, disclosing key ESG metrics and sustainability initiatives.

20 Jul 2026

companies

Abbott India FY26 results

Abbott India reported revenue of ₹6,929 Crores for FY 2025-26, an 8.1% increase. The Board recommended a total dividend of ₹656 per share.

20 Jul 2026

companies

Abbott India appoints two directors via postal ballot

Abbott India Limited announced the appointment of Mr. James Wenner and Mr. Neeraj Jain as directors following a postal ballot. The resolutions received overwhelming shareholder approval with over 99.99% votes in favour.

17 Jun 2026

companies

Abbott India sets July 24 record date for dividend

Abbott India announced a record date of July 24, 2026, for a final dividend of ₹525 and a special dividend of ₹131 per share. The company detailed TDS compliance requirements under the Income Tax Act, 2025.

15 Jun 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number